WALTHAM, Mass. , July 11, 2019 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO) announced today that it plans to issue its 2019 second quarter financial results before the opening of the market on Thursday, July 18, 2019 . The Company will host a conference call at 8:00 a.m., Eastern Time on

WALTHAM, Mass. , July 18, 2019 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO ) today reported financial and business highlights for the quarter ended June 30, 2019 . The Company develops and markets novel therapies for chronic health conditions employing neurostimulation and digital medicine.

WOBURN, Mass. , Oct. 10, 2019 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO) announced today that it plans to issue its 2019 third quarter financial results before the opening of the market on Thursday, October 17, 2019 . The Company will host a conference call at 8:00 a.m., Eastern Time on

WOBURN, Mass. , Oct. 15, 2019 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO), a health technology company that develops and commercializes products for the chronic pain and diabetes markets, today announced important updates to its Quell ® 2.0 commercial strategy.  This novel wearable device

WOBURN, Mass. , Oct. 17, 2019 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO ) today reported financial and business highlights for the quarter ended September 30, 2019 . The Company develops and commercializes products for the chronic pain and diabetes markets that utilize neurostimulation

Shares of Common Stock and Certain Warrants Will Begin Trading on a Split-Adjusted Basis on November 19, 2019 WOBURN, Mass. , Nov. 18, 2019 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (NASDAQ:NURO) today announced the effectiveness of a one-for-ten reverse split of its common stock.

WOBURN, Mass. , Jan. 17, 2020 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO) announced today that it plans to issue its 2019 fourth quarter and full year financial results before the opening of the market on Thursday, January 23, 2020 . The Company will host a conference call at 8:00 a.m.,

WOBURN, Mass. , Jan. 22, 2020 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO) today announced the shift of its 2019 financial conference call to Monday, January 27, 2020 at 8:00am Eastern Time . Internal scheduling conflicts caused the delay of two business days.

WOBURN, Mass. , Jan. 27, 2020 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO ) today reported financial and business highlights for the quarter and year ended December 31, 2019 . The Company develops and commercializes diagnostic and therapeutic neurostimulation-based medical devices.

WOBURN, Mass. , Feb. 25, 2020 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported that it will present two scientific posters at the American Academy of Pain Medicine (AAPM) 36 th Annual Meeting to be held February 26 - March 1 in National Harbor , MD.